Our study shows that multiple immune genes associated with ASCC3, including JAK1, NFKB1, SEMA5A, NR2C2, CNTF and CREB1, positively impact the prognosis of rectal adenocarcinoma patients. This evidence concerns the gene SEMA5A and rectum adenocarcinoma.